CRIS Current Research Information System

SERRETTI, ALESSANDRO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 25.921
EU - Europa 16.600
AS - Asia 7.693
AF - Africa 843
OC - Oceania 63
SA - Sud America 63
Continente sconosciuto - Info sul continente non disponibili 17
Totale 51.200
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 25.860
GB - Regno Unito 5.347
CN - Cina 2.956
DE - Germania 2.877
IT - Italia 1.988
SE - Svezia 1.907
VN - Vietnam 1.695
SG - Singapore 1.576
UA - Ucraina 1.140
IN - India 1.035
FR - Francia 873
RU - Federazione Russa 716
IE - Irlanda 705
ZA - Sudafrica 449
EE - Estonia 406
JO - Giordania 206
TG - Togo 180
BG - Bulgaria 102
CI - Costa d'Avorio 102
CH - Svizzera 87
SC - Seychelles 84
AT - Austria 77
JP - Giappone 64
FI - Finlandia 62
BE - Belgio 60
AU - Australia 55
NL - Olanda 49
GR - Grecia 48
CA - Canada 47
PL - Polonia 39
BR - Brasile 32
ES - Italia 31
LB - Libano 31
HK - Hong Kong 22
RO - Romania 22
CZ - Repubblica Ceca 19
IL - Israele 17
CL - Cile 15
UZ - Uzbekistan 15
EU - Europa 14
IR - Iran 14
MX - Messico 12
TR - Turchia 11
KR - Corea 10
CO - Colombia 8
HU - Ungheria 8
NZ - Nuova Zelanda 8
HR - Croazia 7
NG - Nigeria 6
NO - Norvegia 6
PH - Filippine 6
DZ - Algeria 5
LT - Lituania 4
MU - Mauritius 4
MY - Malesia 4
PE - Perù 4
PT - Portogallo 4
TH - Thailandia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BD - Bangladesh 3
DK - Danimarca 3
EG - Egitto 3
IQ - Iraq 3
KZ - Kazakistan 3
PK - Pakistan 3
RS - Serbia 3
SA - Arabia Saudita 3
SK - Slovacchia (Repubblica Slovacca) 3
TW - Taiwan 3
AE - Emirati Arabi Uniti 2
KE - Kenya 2
MA - Marocco 2
MT - Malta 2
PA - Panama 2
RW - Ruanda 2
SI - Slovenia 2
TN - Tunisia 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BW - Botswana 1
EC - Ecuador 1
ET - Etiopia 1
FK - Isole Falkland (Malvinas) 1
GE - Georgia 1
ID - Indonesia 1
IS - Islanda 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LV - Lettonia 1
MN - Mongolia 1
VE - Venezuela 1
Totale 51.200
Salva come PNG Salva come JPEG
Città #
Southend 4.806
Fairfield 4.502
Ashburn 2.456
Woodbridge 2.109
Seattle 1.935
Wilmington 1.867
Houston 1.804
Cambridge 1.517
Singapore 1.361
Chandler 1.259
Ann Arbor 1.256
Princeton 1.222
Dong Ket 1.065
Jacksonville 733
Dublin 700
Westminster 510
Padova 468
Nanjing 456
Berlin 357
Santa Clara 312
San Diego 274
Saint Petersburg 271
Bologna 265
Shenyang 219
Amman 206
Jinan 205
Mülheim 183
Lomé 180
Turin 175
Hebei 166
Nanchang 159
Changsha 138
Beijing 135
Milan 133
Des Moines 124
Boardman 113
Tianjin 104
Abidjan 102
Dearborn 100
Jiaxing 98
Sofia 98
Guangzhou 94
Los Angeles 89
Mahé 81
Grafing 78
Zhengzhou 71
Falls Church 68
Hangzhou 67
Norwalk 67
Shanghai 66
Haikou 64
Olalla 64
Rome 59
Bern 56
Vienna 56
Tokyo 54
Ningbo 53
Redwood City 50
London 49
Brussels 46
Chicago 46
Bühl 45
Verona 45
Kunming 42
Redmond 40
Paris 39
San Venanzo 39
Taizhou 39
Lanzhou 36
Taiyuan 36
Fuzhou 35
Helsinki 32
Medford 30
Sydney 30
Lappeenranta 28
Pune 27
Wuhan 27
Frankfurt Am Main 25
Warsaw 25
Washington 24
New York 23
Frankfurt am Main 21
Xi'an 21
Forfar 20
Foshan 19
Catania 18
Hefei 18
Plauen 18
São Paulo 18
Tappahannock 18
Buffalo 17
San Francisco 17
Chengdu 15
Harbin 15
Montreal 15
Shenzhen 15
Toronto 15
Qingdao 14
Changchun 13
Costa Mesa 13
Totale 36.408
Salva come PNG Salva come JPEG
Nome #
Novel antipsychotics specificity profile: A clinically oriented review of lurasidone, brexpiprazole, cariprazine and lumateperone 208
Does mindfulness training improve cognitive abilities? A systematic review of neuropsychological findings. 179
5-HTTLPR and gender differences in affective disorders: A systematic review 178
Genomic Dissection of Bipolar Disorder and Schizophrenia, Including 28 Subphenotypes 169
A model to incorporate genetic testing (5-HTTLPR) in pharmacological treatment of major depressive disorders. 164
Psychometric characteristic of the Italian version of the Temperament and Character Inventory-Revised (TCI-R). Personality, psychopathology and attachment styles 163
A neural network model for combining clinical predictors of antidepressant response in mood disorders 155
Should pharmacogenetics be incorporated in major depression treatment? Economic evaluation in high- and middle-income European countries 155
3111T/C clock gene polymorphism is not associated with sleep disturbances in untreated depressed patients 153
Cognitive status, depressive symptoms, and health status as predictors of functional disability among elderly persons with low-to-moderate education: The Faenza Community Aging Study. 152
5-HT(2A) SNPs and the Temperament and Character Inventory 152
Side effects associated with psychotropic medications in patients with bipolar disorder: evidence from two independent samples. 151
The 5-HT2C receptor as a target for mood disorders. 150
A systematic review of neurobiological and clinical features of mindfulness meditations 149
A glycogen synthase kinase 3-beta promoter gene single nucleotide polymorphism is associated with age at onset and response to total sleep deprivation in bipolar depression. 148
CHL1, ITGB3 and SLC6A4 gene expression and antidepressant drug response: Results from the Munich Antidepressant Response Signature (MARS) study 147
Occurrence of cognitive impairment and dementia after the age of 60: a population-based study from Northern Italy. 146
5-HT1A gene variants and psychiatric disorders: a review of current literature and selection of SNPs for future studies 146
Abelson helper integration site-1 gene variants on major depressive disorder and bipolar disorder 146
5-HT2A gene variants influence specific and different aspects of antidepressant response in Japanese and Italian mood disorder patients 144
Age of onset in schizophrenia spectrum disorders: Complex interactions between genetic and environmental factors 143
Antidepressants in healthy subjects: what are the psychotropic/psychological effects? 142
A preliminary investigation of the influence of CREB1 gene on treatment resistance in major depression. 142
Common genetic, clinical, demographic and psychosocial predictors of response to pharmacotherapy in mood and anxiety disorders 141
Adenosine Hypothesis of Antipsychotic Drugs Revisited: Pharmacogenomics Variation in Nonacute Schizophrenia 141
Acute antipyschotic efficacy and side effects in schizophrenia: association with serotonin transporter promoter genotypes 139
Sertraline versus fluvoxamine in the treatment of elderly patients with major depression: a double-blind, randomized trial. 138
5-HT(1A) polymorphism and self-transcendence in mood disorders 137
Correlation of a set of gene variants, life events and personality features on adult ADHD severity 137
Focus on HTR2C: A possible suggestion for genetic studies of complex disorders 136
Association between the estrogen receptor TA polymorphism and Harm avoidance 136
ABCB1 (MDR1) gene polymorphisms are associated with the clinical response to paroxetine in patients with major depressive disorder 135
Genetica dei comportamenti impulsivo-aggressivi: possibile applicazione in psichiatria forense? 135
Antidepressants and body weight: a comprehensive review and meta-analysis 135
Antidepressants in elderly: metaregression of double-blind, randomized clinical trials. 134
Challenging sequential approach to treatment resistant depression: Cost-utility analysis based on the Sequenced Treatment Alternatives to Relieve Depression (STAR⁎D) trial 134
Clinical correlates of augmentation/combination treatment strategies in major depressive disorder 134
A protective genetic variant for adverse environments? The role of childhood traumas and serotonin transporter gene on resilience and depressive severity in a high-risk population 133
Metabolic risk factor profile associated with use of second generation antipsychotics: a cross-sectional study in a community mental health centre 132
Benefit of slow titration of paroxetine to treat depression in the elderly 132
Antidepressivi e disfunzione sessuale: epidemiologia, meccanismi e strategie di trattamento 131
The role of specific early trauma in adult depression: A meta-analysis of published literature. Childhood trauma and adult depression 131
A new prediction model for evaluating treatment-resistant depression 131
COMT and age at onset in mood disorders: a replication and extension study. 131
The association between electrodermal activity (EDA), depression and suicidal behaviour: A systematic review and narrative synthesis 131
Association between GSK-3beta -50T/C polymorphism and personality and psychotic symptoms in mood disorders 130
CRY1 variations impacts on the depressive relapse rate in a sample of bipolar patients 130
Depressive symptomatology is influenced by chronotypes 129
Genetics of late-onset Alzheimer's disease: update from the alzgene database and analysis of shared pathways 128
Thyroid hormones affect recovery from depression during antidepressant treatment 128
A meta-analysis of sexual dysfunction in psychiatric patients taking antipsychotics. 128
Cariprazine specificity profile in the treatment of acute schizophrenia: A meta-Analysis and meta-regression of randomized-controlled trials 127
Monocyte chemoattractant protein-1 promoter -2518 polymorphism and schizophrenia in the Korean population. 126
Actimetric evidence that CLOCK 3111 T/C SNP influences sleep and activity patterns in patients affected by bipolar depression 126
Clinical features, response to treatment and functional outcome of bipolar disorder patients with and without co-occurring substance use disorder: 1-year follow-up 126
Catechol-o-methyltransferase gene modulation on suicidal behavior and personality traits: review, meta-analysis and association study. 126
Association between COMT (Val(158)Met) functional polymorphism and early onset in patients with major depressive disorder in a European multicenter genetic association study 125
Cognitive function and risperidone long-acting injection vs. paliperidone palmitate in schizophrenia: A 6-month, open-label, randomized, pilot trial 124
Genetic Variants Within Key Nodes of the Cascade of Antipsychotic Mechanisms: Effects on Antipsychotic Response and Schizophrenia Psychopathology in a Naturalistic Treatment Setting in Two Independent Korean and Italian Samples 124
Novel Antidepressants and Panic Disorder: Evidence beyond Current Guidelines 123
Antagonist and partial agonist at the dopamine D2 receptors in drug-naïve and non-drug-naïve schizophrenia: a randomized, controlled trial 123
Role of Substance Abuse Comorbidity and Personality on the Outcome of Depression in Bipolar Disorder: Harm Avoidance Influences Medium-Term Treatment Outcome 122
Cognitive markers of psychotic unipolar depression: A meta-analytic study 122
The comparative effects of risperidone long-acting injection and paliperidone palmitate on social functioning in schizophrenia: A 6-month, open-label, randomized controlled pilot trial 122
Collaborative meta-Analysis finds no evidence of a strong interaction between stress and 5-HTTLPR genotype contributing to the development of depression 122
Genome-wide association study identifies 30 loci associated with bipolar disorder 122
Nine differentially expressed genes from a post mortem study and their association with suicidal status in a sample of suicide completers, attempters and controls 121
L'UTILITA' DELLE MEDITAZIONI BASATE SULLA CONSAPEVOLEZZA PER I DISTURBI PSICHIATRICI: UNA REVIEW SISTEMATICA 121
Alcohol Dependence and Genetic Variability in the Serotonin Pathway among Currently and Formerly Alcohol-Dependent Males 120
The microtubule-associated molecular pathways may be genetically disrupted in patients with Bipolar Disorder. Insights from the molecular cascades 119
Depression across mood disorders: review and analysis in a clinical sample. 119
Citalopram versus desipramine in treatment resistant depression: effect of continuation or switching strategies: a randomized open study. 119
The pharmacogenomics of selective serotonin reuptake inhibitors. 118
Metabolic side effects of second generation antipsychotic agents in antipsychotic-naïve patients: One-month prospective evaluation. 118
A genetic dissection of antipsychotic induced movement disorders. 118
Tumor necrosis factor alpha gene-G308A polymorphism associated with bipolar I disorder in the Korean population. 117
Components of self-esteem in affective patients and non-psychiatric controls 117
Antidepressant response in the elderly. 117
APOE epsilon-4 allele and cytokine production in Alzheimer's disease 117
Mindfulness-based stress reduction for stress management in healthy people: a review and meta-analysis 117
Bipolar disorder: "pure" versus mixed depression over a 1-year follow-up. 117
Association analysis of heat shock protein 70 gene polymorphisms in schizophrenia 117
Dimensions of major psychoses: a confirmatory factor analysis of six competing models. 116
Maoa and Maob polymorphisms and personality traits in suicide attempters and healthy controls: a preliminary study 116
22q11.2 rearrangements: clinical and research implications of population-based risk of neuropsychiatric and developmental disorders 116
Serotonin receptor HTR1A and HTR2C variants and personality traits in suicide attempters and controls 115
Progress and prospects in pharmacogenetics of antidepressant drugs 115
Serotonin transporter gene-linked polymorphic region: possible pharmacogenetic implications of rare variants 114
Pharmacological treatment of chronic fatigue syndrome: focusing on the role of antidepressants 114
Vitamin B12 levels in Alzheimer's disease: association with clinical features and cytokine production 114
No Association of TPH1 218A/C Polymorphism with Treatment Response and Intolerance to SSRIs in Japanese Patients with Major Depression 113
Diagnostic accuracy of serum brain derived neurotrophic factor concentration in antidepressant naïve patients with first major depression episode. 113
Clinical factors associated with augmentation treatment with second-generation antipsychotics and lithium in major depression – Results from a European multicenter study 113
The influence of Serotonin Transporter Promoter Polymorphism (SERTPR) and other polymorphisms of the serotonin pathway on the efficacy of antidepressant treatments 112
The C(-1019)G polymorphism of the 5-HT1A gene promoter and antidepressant response in mood disorders: preliminary findings. 112
Temperament and character of suicide attempters 112
Association between Sirtuin 2 gene rs10410544 polymorphism and depression in Alzheimer's disease in two independent European samples. 112
Tardive dyskinesia and DRD2, DRD3, DRD4, 5-HT2A variants in schizophrenia: an association study with repeated assessment. 112
Clinical factors related to schizophrenia relapse 112
Social adjustment could be associated with the serotonin transporter gene in remitted patients with mood disorders and healthy subjects 111
Totale 13.113
Salva come PNG Salva come JPEG
Categoria #
all - tutte 137.794
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 137.794
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202014.206 0 0 0 935 1.666 1.685 2.195 2.302 2.769 990 745 919
2020/20217.549 1.595 631 267 367 137 305 140 582 678 422 348 2.077
2021/20229.193 922 346 678 569 879 569 272 794 311 909 1.658 1.286
2022/20238.083 927 1.151 477 840 509 506 328 456 1.449 242 792 406
2023/20242.420 155 408 196 210 190 373 180 201 106 204 91 106
2024/20253.586 280 1.956 861 489 0 0 0 0 0 0 0 0
Totale 52.261